Skip to main content

Celecoxib

NDC 83301-0028 · Mullan Pharmaceutical Inc.

Generic nameCelecoxib

Dosage formCAPSULE

RouteORAL

Active ingredient(s)CELECOXIB

Strength50 mg/1

Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]

Marketing categoryANDA

Packages

83301-0028-1 — 60 CAPSULE in 1 BOTTLE (83301-0028-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

80425-0323 — Celecoxib, 80425-0382 — Celecoxib, 82009-068 — CELECOXIB, 82009-069 — CELECOXIB, 82804-151 — Celecoxib, 82804-213 — Celecoxib, 82868-034 — Celecoxib, 83008-013 — Celecoxib, 83301-0011 — Celecoxib, 83301-0012 — Celecoxib, 85509-1158 — Celecoxib, 85509-1237 — CELECOXIB, 85534-0014 — celecoxib, 85534-0015 — Celecoxib, 85534-0059 — celecoxib, 85534-0060 — celecoxib, 85534-0065 — celecoxib, 85534-0066 — Celecoxib, 85534-0067 — Celecoxib, 85534-0068 — Celecoxib, +213 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels